Email ID
Password
Scrip   
Sepracor settles US Xopenex patent suit with Teva
19 March 2009
Nancy Faigen

Sepracorhas settled a patent infringement suit with Barr Laboratories, now a part of Teva Pharmaceutical Industries, in connection with the generics firm's ANDA for the short acting beta-agonist Xopenex (levalbuterol HCl inhalation solution), thus permitting Teva to launch generic levalbuterol in the...



Please Login to read the full article.
EVENTS
Today
Cambridge, UK
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36